The vector of anti-pp50 T cell receptor (TCR) is constructed for the engineering of T cell to target CMV pp50. The T cells are genetically modified through transduction with a retroviral vector expressing pp50-specific T cell receptor.https://www.creative-biolabs.com/car-t/anti-pp50-aa245-253-tcr-pcdtcr1-1000.htm

Your Trusted Partner to Advance Your Biological Therapeutics Discovery and Development

Antibody Therapy
Recombinant Antibodies
Bispecific Antibodies (BsAbs)
Antibody-Drug Conjugates (ADCs)
Single Domain Antibodies (SdAbs)
De Novo Antibody Discovery
De Novo Antibody Engineering

Cellular Therapy
Chimeric Antigen Receptor (CAR) Therapy Discovery and Development
Stem Cell Therapy Discovery and Development

Gene Therapy
Oncolytic Virus Discovery and Development
mRNA Discovery and Development
Viral Vector Discovery and Development
RNAi Therapeutics Discovery and Development
Formulation & Delivery Discovery and Development

Excellence in Custom Biotechnology and Pharmaceutical Services

Phage Display & Antibody Library Services
Premade Antibody & Peptide Library Services
Preclinical Animal Model Efficacy Services
PK/PD/Toxicity Evaluation Services
Non-Human Primate (NHP) Biologicals
Membrane Protein Drug Discovery Services